애리조나의 난소암 임상 시험
난소암 관련 연구 26개가 애리조나 내 여러 지역에서 참여자를 모집하고 있습니다.
애리조나의 도시
공식 연구 텍스트(영어)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- CTCA at Western Regional Medical Center, Goodyear
- Kingman Regional Medical Center, Kingman
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05564377A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Gilbert
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Site 0143 - HonorHealth, Phoenix
- Site 0102 - University of Arizona Cancer Center, Tucson
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05128825Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Mayo Clinic, Phoenix
피험자 모집 중관찰 연구
18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05051722DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Banner Health, Gilbert
- Mayo Clinic Hospital, Phoenix
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04981119A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- HonorHealth, Phoenix
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213804Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- University of Arizona Cancer Center, Tucson
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 15. 업데이트됨 · NCT07214779ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Ironwood Cancer & Research Centers, Chandler
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- HonorHealth, Scottsdale
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06400472Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- University of Arizona Cancer Center, Tucson
피험자 모집 중3상
18세 이상 · 여성 · 2026. 8. 26. 업데이트됨 · NCT05281471A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
- Site 0107, Phoenix
피험자 모집 중3상
18세 이상 · 여성 · 2026. 8. 12. 업데이트됨 · NCT07546500A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
피험자 모집 중
35세 ~ 50세 · 여성 · 2026. 8. 7. 업데이트됨 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Cancer Center at Saint Joseph's, Phoenix
- Mayo Clinic Hospital in Arizona, Phoenix
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06580314Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR HonorHealth, Phoenix
- USOR Arizona Oncology Associates, Tucson
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT05579366A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Mayo Clinic (Arizona), Scottsdale
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT04657068AOH1996 for the Treatment of Refractory Solid Tumors
- Honor Health Research and Innovation Institute, Scottsdale
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT05227326Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #108, Goodyear
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06545942Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
- Mayo Clinic Arizona, Phoenix
피험자 모집 중3상
18세 이상 · 여성 · 2026. 7. 14. 업데이트됨 · NCT05804370A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Mayo Clinic Comprehensive Cancer Center, Phoenix
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT05377996A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Banner Health, Gilbert
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 12. 업데이트됨 · NCT06051695A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Phoenix
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06395519MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
- Mayo Clinic in Arizona, Scottsdale
피험자 모집 중1상
18세 이상 · 여성 · 2026. 3. 16. 업데이트됨 · NCT06483048A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center, Tucson
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Mayo Clinic Hospital, Phoenix
- SCRI - Arizona Oncology Associates, PC-HOPE, Tucson
피험자 모집 중2상
18세 이상 · 여성 · 2025. 12. 23. 업데이트됨 · NCT06690775SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.